Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine 4-phosphate is a phosphorylated derivative of glucosamine, belonging to the class of organic compounds known as hexose phosphates[1][4]. Glucosamine and its derivatives are naturally occurring amino sugars involved in the biosynthesis of glycosaminoglycans, which are essential components for building tendons, ligaments, cartilage, and synovial fluid in joints[2][3]. While glucosamine sulfate and hydrochloride salts are widely used as dietary supplements for osteoarthritis and joint pain relief, there is limited specific information on the clinical use or approval status of glucosamine 4-phosphate itself. The mechanism of action for glucosamine compounds generally involves anti-inflammatory effects (such as inhibition of NF-kB), modulation of chondrocyte metabolism (inhibiting p38/JNK pathways), enhancement of matrix formation/collagen synthesis, and support for extracellular matrix remodeling[6]. Glucosamine derivatives may also influence inflammatory markers like IL-1β and IL-6.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine 4-phosphate.